•• Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13:870–84. https://doi.org/10.1016/j.jalz.2017.01.014. This manuscript outlines the consensus criteria for the diagnosis of PCA and provides a framework for the incorporation of biomarkers for the underlying disease.

Article  PubMed  PubMed Central  Google Scholar 

Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021;20:222–34. https://doi.org/10.1016/S1474-4422(20)30440-3.

Article  PubMed  PubMed Central  Google Scholar 

•• Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective. MRI-neuropathology diagnostic accuracy study Lancet Neurol. 2022;21:714–25. https://doi.org/10.1016/S1474-4422(22)00208-3. The authors update the Boston criteria for cerebral amyloid angiopathy. Criteria incorporate white matter changes on MRI and provide.

Article  PubMed  Google Scholar 

Reijmer YD, Fotiadis P, Charidimou A, et al. Relationship between white matter connectivity loss and cortical thinning in cerebral amyloid angiopathy. Hum Brain Mapp. 2017;38:3723–31. https://doi.org/10.1002/hbm.23629.

Article  PubMed  PubMed Central  Google Scholar 

Reijmer YD, Fotiadis P, Martinez-Ramirez S, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain. 2015;138:179–88. https://doi.org/10.1093/brain/awu316.

Article  PubMed  Google Scholar 

• Reijmer YD, Fotiadis P, Riley GA, et al. Progression of brain network alterations in cerebral amyloid angiopathy. Stroke. 2016;47:2470–5. https://doi.org/10.1161/STROKEAHA.116.014337The authors demonstrate that network impairment progresses over time and follows a pattern of progression going from posterior to frontal.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pettersen JA, Sathiyamoorthy G, Gao FQ, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol. 2008;65:790–5. https://doi.org/10.1001/archneur.65.6.790.

Article  PubMed  Google Scholar 

Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther. 2014;345:125–30. https://doi.org/10.1186/alzrt263.

Article  Google Scholar 

Valenti R, Charidimou A, Xiong L, et al. Visuospatial functioning in cerebral amyloid angiopathy: a pilot study. J Alzheimers Dis. 2017;56:1223–7. https://doi.org/10.3233/JAD-160927.

Article  CAS  PubMed  Google Scholar 

Whitwell JL, Kantarci K, Weigand SD, et al. Microbleeds in atypical presentations of Alzheimer’s disease: a comparison to dementia of the Alzheimer’s type. J Alzheimers Dis. 2015;45:1109–17. https://doi.org/10.3233/JAD-142628.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sepehry AA, Lang D, Hsiung GY, et al. Prevalence of brain microbleeds in Alzheimer disease: a systematic review and meta-analysis on the influence of neuroimaging techniques. AJNR Am J Neuroradiol. 2016;37:215–22. https://doi.org/10.3174/ajnr.A4525.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Withington CG, Turner RS. Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer’s disease. Front Neurol. 2022;13:862369. https://doi.org/10.3389/fneur.2022.862369.

Article  PubMed  PubMed Central  Google Scholar 

McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–79. https://doi.org/10.1016/j.jalz.2011.03.005.

Article  PubMed  PubMed Central  Google Scholar 

Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral microbleeds: imaging and clinical significance. Radiology. 2018;287:11–28. https://doi.org/10.1148/radiol.2018170803.

Article  PubMed  Google Scholar 

Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149:351–6. https://doi.org/10.2214/ajr.149.2.351.

Article  CAS  PubMed  Google Scholar 

Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–80. https://doi.org/10.1016/j.neuroimage.2006.01.021.

Article  PubMed  Google Scholar 

Jakel L, De Kort AM, Klijn CJM, et al. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18:10–28. https://doi.org/10.1002/alz.12366.

Article  CAS  PubMed  Google Scholar 

Charidimou A, Zonneveld HI, Shams S, et al. APOE and cortical superficial siderosis in CAA: meta-analysis and potential mechanisms. Neurology. 2019;93(4):e358–71. https://doi.org/10.1212/wnl.0000000000007818.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schott JM, Crutch SJ, Carrasquillo MM, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer’s disease. Alzheimers Dement. 2016;12:862–71. https://doi.org/10.1016/j.jalz.2016.01.010.

Article  PubMed  PubMed Central  Google Scholar 

Millington RS, James-Galton M, Maia Da Silva MN, et al. Lateralized occipital degeneration in posterior cortical atrophy predicts visual field deficits. Neuroimage Clin. 2017;14:242–9.

Article  PubMed  PubMed Central  Google Scholar